Get trending papers in your email inbox once a day!
Get trending papers in your email inbox!
SubscribeVision-based Vineyard Navigation Solution with Automatic Annotation
Autonomous navigation is the key to achieving the full automation of agricultural research and production management (e.g., disease management and yield prediction) using agricultural robots. In this paper, we introduced a vision-based autonomous navigation framework for agriculture robots in trellised cropping systems such as vineyards. To achieve this, we proposed a novel learning-based method to estimate the path traversibility heatmap directly from an RGB-D image and subsequently convert the heatmap to a preferred traversal path. An automatic annotation pipeline was developed to form a training dataset by projecting RTK GPS paths collected during the first setup in a vineyard in corresponding RGB-D images as ground-truth path annotations, allowing a fast model training and fine-tuning without costly human annotation. The trained path detection model was used to develop a full navigation framework consisting of row tracking and row switching modules, enabling a robot to traverse within a crop row and transit between crop rows to cover an entire vineyard autonomously. Extensive field trials were conducted in three different vineyards to demonstrate that the developed path detection model and navigation framework provided a cost-effective, accurate, and robust autonomous navigation solution in the vineyard and could be generalized to unseen vineyards with stable performance.
CRAFT: Exploring Wearable Creative AI on Smart Glasses for Fiction Writing in Real-World Contexts
Creative writing increasingly integrates AI assistance, yet current tools miss in-situ moments when writers draw inspiration from real-world experiences. We envision Context-aware Reality-Fiction Transformation (CRAFT), an approach for AI glasses that translates daily experiences into fiction narratives. We explored its desirability, feasibility, and potential viability through three studies. Interviews with nine writers yielded desires and three design goals: 1) augmenting in-situ perception to bridge reality-fiction gaps, 2) promoting authenticity grounded in real-world experiences while maintaining fictionalization, and 3) preserving creative agency, enjoyment, and life-art boundaries. Co-design workshops with 16 writers and researchers operationalized these goals into concrete interaction mechanisms using a technology probe. We then conducted supported field trials with eight writers across 24 sessions using a refined probe, revealing writer-perceived benefits (e.g., enriched fictional ideas from serendipitous encounters), emergent practices (e.g., micro-creation), and design considerations for future sustained use. We contribute design explorations for the CRAFT approach, offering design implications and empirical insights on ubiquitous human-AI creative collaboration in everyday life.
A review of path following control strategies for autonomous robotic vehicles: theory, simulations, and experiments
This article presents an in-depth review of the topic of path following for autonomous robotic vehicles, with a specific focus on vehicle motion in two dimensional space (2D). From a control system standpoint, path following can be formulated as the problem of stabilizing a path following error system that describes the dynamics of position and possibly orientation errors of a vehicle with respect to a path, with the errors defined in an appropriate reference frame. In spite of the large variety of path following methods described in the literature we show that, in principle, most of them can be categorized in two groups: stabilization of the path following error system expressed either in the vehicle's body frame or in a frame attached to a "reference point" moving along the path, such as a Frenet-Serret (F-S) frame or a Parallel Transport (P-T) frame. With this observation, we provide a unified formulation that is simple but general enough to cover many methods available in the literature. We then discuss the advantages and disadvantages of each method, comparing them from the design and implementation standpoint. We further show experimental results of the path following methods obtained from field trials testing with under-actuated and fully-actuated autonomous marine vehicles. In addition, we introduce open-source Matlab and Gazebo/ROS simulation toolboxes that are helpful in testing path following methods prior to their integration in the combined guidance, navigation, and control systems of autonomous vehicles.
The Common Objects Underwater (COU) Dataset for Robust Underwater Object Detection
We introduce COU: Common Objects Underwater, an instance-segmented image dataset of commonly found man-made objects in multiple aquatic and marine environments. COU contains approximately 10K segmented images, annotated from images collected during a number of underwater robot field trials in diverse locations. COU has been created to address the lack of datasets with robust class coverage curated for underwater instance segmentation, which is particularly useful for training light-weight, real-time capable detectors for Autonomous Underwater Vehicles (AUVs). In addition, COU addresses the lack of diversity in object classes since the commonly available underwater image datasets focus only on marine life. Currently, COU contains images from both closed-water (pool) and open-water (lakes and oceans) environments, of 24 different classes of objects including marine debris, dive tools, and AUVs. To assess the efficacy of COU in training underwater object detectors, we use three state-of-the-art models to evaluate its performance and accuracy, using a combination of standard accuracy and efficiency metrics. The improved performance of COU-trained detectors over those solely trained on terrestrial data demonstrates the clear advantage of training with annotated underwater images. We make COU available for broad use under open-source licenses.
Adaptive Data Augmentation with NaturalSpeech3 for Far-field Speaker Verification
The scarcity of speaker-annotated far-field speech presents a significant challenge in developing high-performance far-field speaker verification (SV) systems. While data augmentation using large-scale near-field speech has been a common strategy to address this limitation, the mismatch in acoustic environments between near-field and far-field speech significantly hinders the improvement of far-field SV effectiveness. In this paper, we propose an adaptive speech augmentation approach leveraging NaturalSpeech3, a pre-trained foundation text-to-speech (TTS) model, to convert near-field speech into far-field speech by incorporating far-field acoustic ambient noise for data augmentation. Specifically, we utilize FACodec from NaturalSpeech3 to decompose the speech waveform into distinct embedding subspaces-content, prosody, speaker, and residual (acoustic details) embeddings-and reconstruct the speech waveform from these disentangled representations. In our method, the prosody, content, and residual embeddings of far-field speech are combined with speaker embeddings from near-field speech to generate augmented pseudo far-field speech that maintains the speaker identity from the out-domain near-field speech while preserving the acoustic environment of the in-domain far-field speech. This approach not only serves as an effective strategy for augmenting training data for far-field speaker verification but also extends to cross-data augmentation for enrollment and test speech in evaluation trials.Experimental results on FFSVC demonstrate that the adaptive data augmentation method significantly outperforms traditional approaches, such as random noise addition and reverberation, as well as other competitive data augmentation strategies.
SemEval-2024 Task 2: Safe Biomedical Natural Language Inference for Clinical Trials
Large Language Models (LLMs) are at the forefront of NLP achievements but fall short in dealing with shortcut learning, factual inconsistency, and vulnerability to adversarial inputs.These shortcomings are especially critical in medical contexts, where they can misrepresent actual model capabilities. Addressing this, we present SemEval-2024 Task 2: Safe Biomedical Natural Language Inference for ClinicalTrials. Our contributions include the refined NLI4CT-P dataset (i.e., Natural Language Inference for Clinical Trials - Perturbed), designed to challenge LLMs with interventional and causal reasoning tasks, along with a comprehensive evaluation of methods and results for participant submissions. A total of 106 participants registered for the task contributing to over 1200 individual submissions and 25 system overview papers. This initiative aims to advance the robustness and applicability of NLI models in healthcare, ensuring safer and more dependable AI assistance in clinical decision-making. We anticipate that the dataset, models, and outcomes of this task can support future research in the field of biomedical NLI. The dataset, competition leaderboard, and website are publicly available.
Does Your Trial Simulator Know What the Drug Does? An Intervention-Blind Test of Interventional Validity on 7,207 Registered Trials
Patient world models are increasingly proposed as simulators of clinical trials, and recent surveys rank their capabilities on a ladder from temporal prediction to counterfactual rollouts. Position on that ladder is currently assigned by reading papers rather than by measurement. We turn the counterfactual rung into a measured quantity. From 30,119 completed phase 2/3 trials with results posted to ClinicalTrials.gov we construct 9,996 audited within-trial contrasts from 7,207 trials, and we score a simulator on how much of its accuracy depends on knowing which intervention was tested. The instrument is an intervention-blind reference: the same model, trained on the same trials, with every intervention-identifying field withheld. Interventional skill is the error the full model removes relative to that reference. On a temporal split (878 test contrasts from 655 trials) a registry-trained gradient-boosting simulator removes a fifth of the error of a trivial baseline, but its interventional skill is -0.12 (95% CI -0.21 to -0.05): withholding the intervention makes it better, and no alternative featurisation, stratum, temporal cut or same-molecule retrieval yields an interval above zero. A frontier language model reading only the registered protocol has interventional skill 0.20 [0.08, 0.31]; smaller and open-weight models sit at the limit of detection. Perturbation tests show the large model uses the intervention as such: swapping the arms reverses the sign of its prediction in 86% of contrasts. The blind reference is itself not drug-blind (a language model recovers the withheld drug class 45% of the time from the blind prompt), so interventional skill is a conservative lower bound. A reliability layer shows that ranking by predicted error lowers it but that calibrated error control does not transfer under temporal shift. Benchmark, code, prompts and per-call model outputs are released.
Remote Auditing: Design-based Tests of Randomization, Selection, and Missingness with Broadly Accessible Satellite Imagery
Randomized controlled trials (RCTs) are the benchmark for causal inference, yet field implementation can deviate. We here present a remote audit - a design-based, preregistrable diagnostic that uses only pre-treatment satellite imagery to test whether assignment is independent of local conditions. The conditional randomization test of the remote audit evaluates whether treatment assignment is more predictable from pre-treatment satellite features than expected under the experiment's registered mechanism, providing a finite-sample valid, design-based diagnostic that requires no parametric assumptions. The procedure is finite-sample valid, honors blocks and clusters, and controls multiplicity across image models and resolutions via a max-statistic. We illustrate with two RCTs: Uganda's Youth Opportunities Program, where the audit corroborates randomization and flags selection and missing-data risks; and a school-based trial in Bangladesh, where assignment is highly predictable from pre-treatment features relative to the stated design, consistent with independent concerns about irregularities. Remote audits complement balance tests, lower early-stage costs, and enable rapid design checks when baseline surveys are expensive or infeasible.
Panacea: A foundation model for clinical trial search, summarization, design, and recruitment
Clinical trials are fundamental in developing new drugs, medical devices, and treatments. However, they are often time-consuming and have low success rates. Although there have been initial attempts to create large language models (LLMs) for clinical trial design and patient-trial matching, these models remain task-specific and not adaptable to diverse clinical trial tasks. To address this challenge, we propose a clinical trial foundation model named Panacea, designed to handle multiple tasks, including trial search, trial summarization, trial design, and patient-trial matching. We also assemble a large-scale dataset, named TrialAlign, of 793,279 trial documents and 1,113,207 trial-related scientific papers, to infuse clinical knowledge into the model by pre-training. We further curate TrialInstruct, which has 200,866 of instruction data for fine-tuning. These resources enable Panacea to be widely applicable for a range of clinical trial tasks based on user requirements. We evaluated Panacea on a new benchmark, named TrialPanorama, which covers eight clinical trial tasks. Our method performed the best on seven of the eight tasks compared to six cutting-edge generic or medicine-specific LLMs. Specifically, Panacea showed great potential to collaborate with human experts in crafting the design of eligibility criteria, study arms, and outcome measures, in multi-round conversations. In addition, Panacea achieved 14.42% improvement in patient-trial matching, 41.78% to 52.02% improvement in trial search, and consistently ranked at the top for five aspects of trial summarization. Our approach demonstrates the effectiveness of Panacea in clinical trials and establishes a comprehensive resource, including training data, model, and benchmark, for developing clinical trial foundation models, paving the path for AI-based clinical trial development.
Image-based Treatment Effect Heterogeneity
Randomized controlled trials (RCTs) are considered the gold standard for estimating the average treatment effect (ATE) of interventions. One use of RCTs is to study the causes of global poverty -- a subject explicitly cited in the 2019 Nobel Memorial Prize awarded to Duflo, Banerjee, and Kremer "for their experimental approach to alleviating global poverty." Because the ATE is a population summary, anti-poverty experiments often seek to unpack the effect variation around the ATE by conditioning (CATE) on tabular variables such as age and ethnicity that were measured during the RCT data collection. Although such variables are key to unpacking CATE, using only such variables may fail to capture historical, geographical, or neighborhood-specific contributors to effect variation, as tabular RCT data are often only observed near the time of the experiment. In global poverty research, when the location of the experiment units is approximately known, satellite imagery can provide a window into such factors important for understanding heterogeneity. However, there is no method that specifically enables applied researchers to analyze CATE from images. In this paper, using a deep probabilistic modeling framework, we develop such a method that estimates latent clusters of images by identifying images with similar treatment effects distributions. Our interpretable image CATE model also includes a sensitivity factor that quantifies the importance of image segments contributing to the effect cluster prediction. We compare the proposed methods against alternatives in simulation; also, we show how the model works in an actual RCT, estimating the effects of an anti-poverty intervention in northern Uganda and obtaining a posterior predictive distribution over effects for the rest of the country where no experimental data was collected. We make all models available in open-source software.
TrialPanorama: Database and Benchmark for Systematic Review and Design of Clinical Trials
Developing artificial intelligence (AI) for vertical domains requires a solid data foundation for both training and evaluation. In this work, we introduce TrialPanorama, a large-scale, structured database comprising 1,657,476 clinical trial records aggregated from 15 global sources. The database captures key aspects of trial design and execution, including trial setups, interventions, conditions, biomarkers, and outcomes, and links them to standard biomedical ontologies such as DrugBank and MedDRA. This structured and ontology-grounded design enables TrialPanorama to serve as a unified, extensible resource for a wide range of clinical trial tasks, including trial planning, design, and summarization. To demonstrate its utility, we derive a suite of benchmark tasks directly from the TrialPanorama database. The benchmark spans eight tasks across two categories: three for systematic review (study search, study screening, and evidence summarization) and five for trial design (arm design, eligibility criteria, endpoint selection, sample size estimation, and trial completion assessment). The experiments using five state-of-the-art large language models (LLMs) show that while general-purpose LLMs exhibit some zero-shot capability, their performance is still inadequate for high-stakes clinical trial workflows. We release TrialPanorama database and the benchmark to facilitate further research on AI for clinical trials.
Follow Nudges without Budges: A Field Experiment on Misinformation Followers Didn't Change Follow Networks
Can digital ads encourage users exposed to inaccurate information sources to follow accurate ones? We conduct a large-scale field experiment (N=28,582) on X, formerly Twitter, with users who follow accounts that spread health misinformation. Participants were exposed to four ad treatments varied on two dimensions: a neutral message versus a persuasive message appealing to values of independence, and a request to follow a health institution versus a request to follow a health influencer. We term this ad-based, social network intervention a follow nudge. The ad with a persuasive message to follow a well-known health institution generated significantly higher click-through rates than all other conditions (Bonferroni-corrected pairwise tests, all p<0.001). Given the overall low click-through rate across treatments and the high cost of digital advertising infrastructure on X, however, we conclude that our proposed intervention -- at least in its current ad-based format -- is not a cost-effective means to improve information environments online. We discuss challenges faced when conducting large-scale experiments on X following the platform's ownership change and subsequent restrictions on data access for research purposes.
A smartphone application to measure the quality of pest control spraying machines via image analysis
The need for higher agricultural productivity has demanded the intensive use of pesticides. However, their correct use depends on assessment methods that can accurately predict how well the pesticides' spraying covered the intended crop region. Some methods have been proposed in the literature, but their high cost and low portability harm their widespread use. This paper proposes and experimentally evaluates a new methodology based on the use of a smartphone-based mobile application, named DropLeaf. Experiments performed using DropLeaf showed that, in addition to its versatility, it can predict with high accuracy the pesticide spraying. DropLeaf is a five-fold image-processing methodology based on: (i) color space conversion, (ii) threshold noise removal, (iii) convolutional operations of dilation and erosion, (iv) detection of contour markers in the water-sensitive card, and, (v) identification of droplets via the marker-controlled watershed transformation. The authors performed successful experiments over two case studies, the first using a set of synthetic cards and the second using a real-world crop. The proposed tool can be broadly used by farmers equipped with conventional mobile phones, improving the use of pesticides with health, environmental and financial benefits.
From Given to Gathered Evidence: Agentic Learning for Longitudinal Medical Reasoning
Foundation models can serve as clinical agents through tool-use harnesses. However, conventional medical benchmarks assess reasoning over preselected evidence rather than the ability to seek it across clinical records and longitudinal imaging. We propose CASE: a series of role-specific Clinical Agents for Seeking Evidence, together with a tool-use harness and an agentic post-training framework for compact vision-language policy models. We further introduce a longitudinal multimodal benchmark built on UK Biobank, comprising 50,401 clinical questions derived from real-world ICD-10-coded diagnoses of 4,739 participants. Each question links to a patient-specific environment containing clinical context and multi-sequence MRI from baseline and follow-up visits, where agents autonomously select which visits, organs, modalities, slices, and specialist tools to inspect and compare. Supervised fine-tuning transfers evidence-seeking workflows from 14,734 frontier-model interaction trajectories, followed by agentic reinforcement learning on the learner's own environment interactions. Privileged on-policy self-distillation and rubric-based LLM feedback refine evidence-to-conclusion reasoning without prescribing tool sequences. Experiments show that CASE moves beyond question-answer imitation toward transferable investigation policies, strengthening evidence-grounded longitudinal reasoning. Under matched evaluation conditions, our Qwen3-VL-8B based agent achieves over 16% and 10% relative improvements in answer accuracy over GPT-5.4 and Claude Opus 4.8. Code will be available at https://github.com/VinyehShaw/CASE.
Technical Report on the Turba Fertilizer Machine Learning Stack in Morocco
Site-specific fertilizer recommendation systems adapt nutrient advice to location, soil properties, crop type, and production targets, but scientific reuse is constrained when recommendation functions remain accessible mainly through interactive interfaces, outputs are not versioned, and trained approximations cannot be independently loaded or benchmarked. This technical report presents the Turba fertilizer machine learning stack, a three-layer open-source implementation for reproducible site-specific fertilizer recommendation in Morocco. turba-client provides programmatic access to publicly accessible site profiles, crop-specific target-yield spaces, and N, P_2O_5, and K_2O recommendation workflows; turba-data distributes analysis-ready snapshots; and turba-models packages crop-specific machine learning surrogates of recommendation outputs. The architecture links upstream retrieval, versioned analytical snapshots, reproducible cross-model benchmarking, and loadable offline surrogates while preserving the distinction between recommendation-system outputs, observed agricultural data, and model-generated predictions. The first dataset was constructed from 44,096 unique ESA WorldCereal locations. Scenario expansion across supported cereal workflows generated 132,017 crop-location recommendation requests under a medium target-yield setting. The resulting 22-variable dataset spans 10 regions, 66 provinces, and 1,149 communes. Nine regression families were evaluated under a fixed deterministic 80/20 protocol, and the current release packages five best-performing crop-specific models. The machine learning task is recommendation-function emulation rather than prediction of observed crop response. The stack provides a reproducible basis for spatial and temporal validation, uncertainty estimation, field-trial comparison, and future integration with additional data.
Scaling Clinical Trial Matching Using Large Language Models: A Case Study in Oncology
Clinical trial matching is a key process in health delivery and discovery. In practice, it is plagued by overwhelming unstructured data and unscalable manual processing. In this paper, we conduct a systematic study on scaling clinical trial matching using large language models (LLMs), with oncology as the focus area. Our study is grounded in a clinical trial matching system currently in test deployment at a large U.S. health network. Initial findings are promising: out of box, cutting-edge LLMs, such as GPT-4, can already structure elaborate eligibility criteria of clinical trials and extract complex matching logic (e.g., nested AND/OR/NOT). While still far from perfect, LLMs substantially outperform prior strong baselines and may serve as a preliminary solution to help triage patient-trial candidates with humans in the loop. Our study also reveals a few significant growth areas for applying LLMs to end-to-end clinical trial matching, such as context limitation and accuracy, especially in structuring patient information from longitudinal medical records.
Auto Research with Specialist Agents Develops Effective and Non-Trivial Training Recipes
We study auto research as a closed empirical loop driven by external measurement. Each submitted trial carries a hypothesis, an executable code edit, an evaluator-owned outcome, and feedback that shapes the next proposal. The output is not a generated paper or a single model checkpoint, but an auditable trajectory of proposals, code diffs, experiments, scores, and failure labels. We instantiate this loop with specialist agents that partition recipe surfaces and share measured lineage across trials. The central empirical finding is that lineage feedback lets agents turn evaluator outcomes, including crashes, budget overruns, size failures, and accuracy-gate misses, into later program-level recipe edits rather than one-shot suggestions. Across 1,197 headline-run trials plus 600 Parameter Golf control trials after one-time setup and launch, humans did not choose proposals, edit recipes, override scores, or repair failed trials during the search. In the three headline runs, the same submitted-trial loop reduces Parameter Golf validation bpb by 0.81%, raises NanoChat-D12 CORE by 38.7%, and reduces CIFAR-10 Airbench96 wallclock by 4.59%, with each task measured by its own external evaluator and legality checks. The trace includes a strict architecture-domain audit of 157 headline-run submissions and program rewrites such as a NanoChat attention-kernel path change. Within this scope the loop autonomously writes code, submits experiments, absorbs feedback, applies and combines known techniques inside each environment, and improves public starting recipes.
PRISM: Patient Records Interpretation for Semantic Clinical Trial Matching using Large Language Models
Clinical trial matching is the task of identifying trials for which patients may be potentially eligible. Typically, this task is labor-intensive and requires detailed verification of patient electronic health records (EHRs) against the stringent inclusion and exclusion criteria of clinical trials. This process is manual, time-intensive, and challenging to scale up, resulting in many patients missing out on potential therapeutic options. Recent advancements in Large Language Models (LLMs) have made automating patient-trial matching possible, as shown in multiple concurrent research studies. However, the current approaches are confined to constrained, often synthetic datasets that do not adequately mirror the complexities encountered in real-world medical data. In this study, we present the first, end-to-end large-scale empirical evaluation of clinical trial matching using real-world EHRs. Our study showcases the capability of LLMs to accurately match patients with appropriate clinical trials. We perform experiments with proprietary LLMs, including GPT-4 and GPT-3.5, as well as our custom fine-tuned model called OncoLLM and show that OncoLLM, despite its significantly smaller size, not only outperforms GPT-3.5 but also matches the performance of qualified medical doctors. All experiments were carried out on real-world EHRs that include clinical notes and available clinical trials from a single cancer center in the United States.
Bayesian aggregation of average data: An application in drug development
Throughout the different phases of a drug development program, randomized trials are used to establish the tolerability, safety, and efficacy of a candidate drug. At each stage one aims to optimize the design of future studies by extrapolation from the available evidence at the time. This includes collected trial data and relevant external data. However, relevant external data are typically available as averages only, for example from trials on alternative treatments reported in the literature. Here we report on such an example from a drug development for wet age-related macular degeneration. This disease is the leading cause of severe vision loss in the elderly. While current treatment options are efficacious, they are also a substantial burden for the patient. Hence, new treatments are under development which need to be compared against existing treatments. The general statistical problem this leads to is meta-analysis, which addresses the question of how we can combine datasets collected under different conditions. Bayesian methods have long been used to achieve partial pooling. Here we consider the challenge when the model of interest is complex (hierarchical and nonlinear) and one dataset is given as raw data while the second dataset is given as averages only. In such a situation, common meta-analytic methods can only be applied when the model is sufficiently simple for analytic approaches. When the model is too complex, for example nonlinear, an analytic approach is not possible. We provide a Bayesian solution by using simulation to approximately reconstruct the likelihood of the external summary and allowing the parameters in the model to vary under the different conditions. We first evaluate our approach using fake-data simulations and then report results for the drug development program that motivated this research.
rTaste: Do Research Agents Have Taste? Evaluating Early Stage Research Judgment
Do research agents have taste, the judgment of which experiments are worth running before their outcomes are known? We give six frontier models seven recent NLP papers. Each model, working as a research agent alone or as a team, proposes minimum viable experiments (MVEs), forecasts whether each will pass a threshold it sets and ranks them. A separate executor then attempts every MVE, including those ranked last, and three model auditors judge the results. Of 415 MVEs, 194 are judged sound, valuable and new, but fewer than half of these (73) are also judged beyond the seed paper and non obvious. The agents' first choices match the auditors' most valued experiment more often than a random pick, but are not shown to improve on choosing the experiment written first. Their forecasts beat a base rate but are not measurably more accurate than those of a fresh instance of the same model given only the paper and registrations. Teams cost more without a clear overall improvement in proposal quality. The agents produce many worthwhile experiments, but the evidence that their rankings improve the choice of which to run remains limited. The evaluation harness and a dataset of all 415 MVEs, with their forecasts and audited outcomes, are available at https://github.com/ArtKanke/rTaste.
Matching Patients to Clinical Trials with Large Language Models
Patient recruitment is challenging for clinical trials. We introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models. TrialGPT comprises three modules: it first performs large-scale filtering to retrieve candidate trials (TrialGPT-Retrieval); then predicts criterion-level patient eligibility (TrialGPT-Matching); and finally generates trial-level scores (TrialGPT-Ranking). We evaluate TrialGPT on three cohorts of 183 synthetic patients with over 75,000 trial annotations. TrialGPT-Retrieval can recall over 90% of relevant trials using less than 6% of the initial collection. Manual evaluations on 1,015 patient-criterion pairs show that TrialGPT-Matching achieves an accuracy of 87.3% with faithful explanations, close to the expert performance. The TrialGPT-Ranking scores are highly correlated with human judgments and outperform the best-competing models by 43.8% in ranking and excluding trials. Furthermore, our user study reveals that TrialGPT can reduce the screening time by 42.6% in patient recruitment. Overall, these results have demonstrated promising opportunities for patient-to-trial matching with TrialGPT.
PhenoBench -- A Large Dataset and Benchmarks for Semantic Image Interpretation in the Agricultural Domain
The production of food, feed, fiber, and fuel is a key task of agriculture, which has to cope with many challenges in the upcoming decades, e.g., a higher demand, climate change, lack of workers, and the availability of arable land. Vision systems can support making better and more sustainable field management decisions, but also support the breeding of new crop varieties by allowing temporally dense and reproducible measurements. Recently, agricultural robotics got an increasing interest in the vision and robotics communities since it is a promising avenue for coping with the aforementioned lack of workers and enabling more sustainable production. While large datasets and benchmarks in other domains are readily available and enable significant progress, agricultural datasets and benchmarks are comparably rare. We present an annotated dataset and benchmarks for the semantic interpretation of real agricultural fields. Our dataset recorded with a UAV provides high-quality, pixel-wise annotations of crops and weeds, but also crop leaf instances at the same time. Furthermore, we provide benchmarks for various tasks on a hidden test set comprised of different fields: known fields covered by the training data and a completely unseen field. Our dataset, benchmarks, and code are available at https://www.phenobench.org.
